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Background and purpose   The outcome of modern resurfacing 
remains to be determined. The Australian Orthopaedic Associa-
tion National Joint Replacement Registry (AOANJRR) started 
collection of data on hip resurfacing at a time when modern resur-
facing was started in Australia. The rate of resurfacing has been 
higher in Australia than in many other countries. As a result, the 
AOANJRR has one of the largest series of resurfacing procedures. 
This study was undertaken to determine the results of this series 
and the risk factors associated with revision. 
Patients and methods   Data from the AOANJRR were used 
to analyze the survivorship of 12,093 primary resurfacing hip 
replacements reported to the Joint Replacement Registry between 
September 1999 and December 2008. This was compared to the 
results of primary conventional total hip replacement reported 
during the same period. The Kaplan-Meier method and propor-
tional hazards models were used to determine risk factors such as 
age, sex, femoral component size, primary diagnosis, and implant 
design.
Results   Female patients had a higher revision rate than males; 
however, after adjusting for head size, the revision rates were sim-
ilar. Prostheses with head sizes of less than 50 mm had a higher 
revision rate than those with head sizes of 50 mm or more. At 8 
years, the cumulative per cent revision of hip resurfacing was 5.3 
(4.6–6.2), as compared to 4.0 (3.8–4.2) for total hip replacement. 
However, in osteoarthritis patients aged less than 55 years with 
head sizes of 50 mm or more, the 7-year cumulative per cent revi-
sion for hip resurfacing was 3.0 (2.2–4.2). Also, hips with dysplasia 
and some implant designs had an increased risk of revision.
Interpretation   Risk factors for revision of resurfacing were 
older patients, smaller femoral head size, patients with develop-
mental dysplasia, and certain implant designs. These results high-
light the importance of patient and prosthesis selection in optimiz-
ing the outcome of hip resurfacing. 

Conventional total hip replacement gives good outcome in 
older patients, but younger patients have higher revision rates 
(Boerre and Bannister 1993, Joshi et al. 1993, Dorr et al. 1994, 
Callaghan  et  al.  1997,  Swedish  Hip Arthroplasty  Register 
Annual Report 2006). Resurfacing of the hip using a metal-
on-metal, large-diameter bearing has theoretical advantages, 
particularly in younger patients. These include bone conserva-
tion, restoration of proximal femoral anatomy, low wear rates, 
and ease of future revision. Recent publications have reported 
promising results (Amstutz et al. 2004, Daniel et al. 2004, 
Back et al. 2005, Treacy et al. 2005, Girard et al. 2006, Pollard 
et al. 2006, Mont et al. 2007), especially in younger patients. 
There remain concerns, however, regarding increased risk of 
femoral neck fractures, metal ion release, and formation of 
pseudotumors (Shimmin and Back 2005, Grammatopoulos et 
al. 2009).
In  Australia,  hip  resurfacing  has  been  performed  and 
recorded in the Australian Orthopaedic Association National 
Joint  Replacement  Registry  (AOANJRR)  since  1999.  This 
report examines the 12,093 hip resurfacings reported to the 
Registry and evaluates risk factors for revision.
Patients and methods
The AOANJRR started collection of data in September 1999. 
It was implemented in a stepwise manner, becoming fully 
operational on a national basis in 2002. All hospitals under-
taking joint replacement surgery contribute data to the Reg-
istry. Cross-validation of procedures reported to the Registry 
with independently colleced health department data ensures 
that almost all hip procedures are recorded by the Registry. 
The present analysis includes all primary conventional and 
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up to and including December 2008 (147,422 hips in 129,992 
patients and 12,093 hips in 10,489 patients, respectively).
Statistics
The cumulative per cent revision (CPR) of primary total hip 
replacements was estimated at each of the first 8 years using 
the Kaplan-Meier method. Unadjusted CPR (with 95% con-
fidence intervals) is reported. Hazard ratios (HRs) from Cox 
proportional hazards models, adjusting for age and sex where 
appropriate, were used to compare revision rates. 
For each model, the assumption of proportional hazards was 
checked analytically. If the interaction between the predictor 
and the log of time was statistically significant in the stan-
dard Cox model, then a time varying model was estimated. 
Time points were selected based on the greatest change in 
hazard, weighted by a function of events. Time points were 
iteratively chosen until the assumption of proportionality was 
met; then the hazard ratios were calculated for each selected 
time period. In our results, if no time period is specified then 
the hazard ratio covers the entire follow-up period. Adjust-
ment for bilaterality was not performed, as no bias in includ-
ing bilateral replacements could be expected (Robertsson and 
Ranstam 2003).
All tests were two-tailed at the 5% level of significance. 
Analyses comparing outcomes of age, sex, and head size for 
resurfacing  hip  procedures,  and  conventional  total  versus 
resurfacing hip procedures, were performed on patients with 
primary diagnosis of osteoarthritis (OA) excluding revisions 
for infection.
Results
Conventional versus resurfacing
The use of hip resurfacing increased from 6% of all primary 
total hip replacements in 2001 to 9% in 2005, but then gradu-
ally declined each subsequent year to 6% in 2008. Overall, hip 
resurfacing had a higher revision rate than conventional total 
hip replacement (age- and sex-adjusted HR = 1.4 (1.2–1.6)). 
The 8-year CPR for hip resurfacing was 5.3 (4.6–6.2), as com-
pared to 4.0 (3.8–4.2) for conventional total hip replacement 
(Figure 1). 
Primary diagnosis
Nearly all patients undergoing primary resurfacing hip replace-
ment had a primary diagnosis of osteoarthritis (OA) (94%). 
Patients with developmental dysplasia of the hip (DDH) had a 
higher rate of revision than those patients with OA (age- and 
sex-adjusted HR = 2.1 (1.4–3.1)) (Figure 2). The 5-year CPR 
for DDH patients was 12 (8–17) as compared to 4.1 (3.7–4.6) 
for OA patients. There was no difference in the rate of revi-
sion  between  avascular  necrosis  (AVN)  and  OA  (age-  and 
sex-adjusted HR = 1.6 (0.9–2.9)). The 5-year CPR for AVN 
patients was 6.3 (3.5–11). The 5-year CPR for inflammatory 
arthritis was 8 (4–18); however, the numbers are too small for 
a valid statistical comparison.
Age, sex, and head size
In 2008, 55% of the hip resurfacings were performed in patients 
aged less than 55 years, 38% were performed in patients aged 
55–64, 7% in patients aged 65–74, and 1% in patients who 
were 75 years or older. This distribution has shown a slight 
increase in the proportion of younger patients (less than 65) in 
Figure 1. Cumulative percent revision of primary conventional total and 
total resurfacing hip replacement (primary diagnosis: OA, excluding 
infection).
Figure 2. Cumulative percent revision of primary total resurfacing hip 
replacement, by primary diagnosis.
Age 55–64 vs. < 55   Entire period: HR = 1.3 (1.0–1.6), p = 0.04
Age 65–74 vs. < 55   Entire period: HR = 1.7 (1.2–2.5), p = 0.001
Age ≥ 75    vs. < 55    0–3 months: HR = 14.0 (5.7–35), p < 0.001 
       > 3 months: HR = 0.9 (0.1–6.1), p = 0.968  Acta Orthopaedica 2010; 81 (1): 66–71
recent years. In patients with a diagnosis of OA, resurfacing 
procedures had an increasing risk of revision with increasing 
age (Figure 3). This is unlike conventional total hip replace-
ment, where the risk of revision decreases with increasing 
age.
The proportion of hip resurfacings performed in females 
decreased steadily from 31% in 2002 to 20% in 2008. Females 
had a higher revision rate than males (age-adjusted HR = 2.2 
(1.8–2.7)) (Figure 4). However, a higher proportion of females 
(65%) received head sizes less than 50 mm, and after adjust-
ing for head size there was no difference in the rate of revision 
between males and females (age- and head-size adjusted HR = 
1.0 (0.7–1.3)). For each sex, head sizes of less than 50 mm had 
a statistically significantly higher rate of revision than head 
sizes of 50 mm or greater (Figure 5).
The 7-year outcome of primary resurfacing hip replacement 
in younger patients with a femoral head size of greater than 50 
mm had a similar outcome to conventional total hip replace-
ment at the same age. The 7-year CPR for hip resurfacing for 
those aged less than 55 years was 3.0 (2.2–4.2) and for those 
aged 55–64 it was 3.1 (2.3–4.2). 
Implant design
Since the introduction of modern hip resurfacing procedures, 
there has been a steady increase in the number of types of pros-
theses being used. In 2008, 13 types of resurfacing prostheses 
were used (Table 1). The Birmingham Hip Resurfacing (BHR) 
has remained the most frequently used prosthesis, making up 
51% of all resurfacings in 2008. Its proportional use has, how-
ever, decreased from 96% in 2001. Up to the end of 2008, 
there were 9 resurfacing prostheses with over 100 procedures 
each recorded by the Registry. Of these, 3 prostheses had a 
statistically significantly higher revision rate than all other 
resurfacing procedures, as did 1 other prosthesis with 95 pro-
cedures. These prostheses were ASR (age- and sex-adjusted 
HR = 2.2 (1.7–2.9)), Durom (age- and sex-adjusted HR = 1.7 
(1.2–2.4)), Cormet 2000 HAP (age- and sex-adjusted HR = 3 
(1–5)) and Recap (age- and sex-adjusted HR = 3(1–5)). The 
ASR, Durom, and Recap prostheses were introduced to the 
Australian market after the BHR. Their outcome differs from 
that of other new prostheses with over 100 procedures, includ-
ing the Adept and Mitch TRH, which had a CPR similar to that 
of the BHR at 3 years (Table 1).
The rate of revision for fracture in OA patients receiving hip 
resurfacing differed between the resurfacing prostheses. The 
BHR had the lowest risk of revision for fracture, with a CPR 
Figure 4. Cumulative per cent revision of primary total resurfacing hip 
replacement, by sex (primary diagnosis: OA, excluding infection).
< 50 mm vs. ≥ 50 mm:
  male,   Entire period: HR = 2.4 (1.8–3.3), p < 0.001
  female,    Entire period: HR = 3.7 (1.7–7.9), p < 0.001 
Female vs. male: 
  < 50 mm,  Entire period: HR = 1.2 (0.9–1.7), p = 0.2
	≥  50 mm,  Entire period: HR = 0.8 (0.4–1.7), p = 0.6
Figure 3. Cumulative per cent revision of primary total resurfacing hip 
replacement, by age (primary diagnosis: OA, excluding infection).
Figure 5. Cumulative per cent revision of primary total resurfacing hip 
replacement, by sex and femoral component head size (primary diag-
nosis: OA, excluding infection).Acta Orthopaedica 2010; 81 (1): 66–71  69
for fracture at 5 years of 1.2 (1.0–1.5) and a slight increase to 
1.5 (1.2–1.9) at 8 years. When considering the prostheses with 
more than 100 procedures, 3 had a higher risk of revision for 
fracture than the BHR: the ASR (age- and sex-adjusted HR = 3 
(2–5) p), the Durom (age- and sex-adjusted HR = 2 (1–4)), and 
the Recap (age- and sex-adjusted HR = 3 (1–9)). 
Revisions
Of the 12,093 hip resurfacings, 437 (3.6%) had been revised. 
Over half of the revisions were femoral-only revisions and 
one third were both femoral and acetabular revisions (Table 
2).  The  most  common  reasons  for  revision  were  fracture, 
loosening/lysis, infection, and metal sensitivity (Table 3). The 
reason for revision changed with age, with an increase in revi-
sion for fracture with increasing age (1% of patients aged less 
than 55 years, 2% of patients aged between 55 and 64, 3% of 
patients aged between 65 and 74, and 9% of patients aged 75 
and older). Females were not only revised more frequently for 
fracture than males (1.8% and 1.3%, respectively) but also for 
loosening/lysis (2.0% and 0.7%, respectively). 
Discussion
With improvements in metal-on-metal bearing technology, hip 
resurfacing has gained popularity as an alternative to conven-
tional total hip replacement in younger, active patients. Recent 
studies have shown promising results (Amstutz et al. 2004, 
Daniel et al. 2004, Back et al. 2005, Treacy et al. 2005, Girard 
et al. 2006, Pollard et al. 2006, Mont et al. 2007). It is generally 
accepted that younger patients with total hip replacements are 
at highest risk of revision (Boerre and Bannister 1993, Joshi et 
al. 1993, Dorr et al. 1994, Callaghan et al. 1997, Swedish Hip 
Arthroplasty Register Annual Report 2006). The Australian 
Joint Registry has reported an increase in the risk of revision 
(at 8 years) for patients less than 65 years with conventional 
total hip replacement (AOANJRR Annual Report 2009). 
Our analysis shows that overall, primary hip resurfacing has 
a higher risk of revision than conventional total hip replace-
ment after adjusting for age and sex. At 8 years, the CPR of 
hip resurfacing is 5.3 (4.6–6.2) as compared to 4.0 (3.8–4.2) 
for conventional total hip replacement. This difference was 
not apparent in patients aged less than 65 years with a femoral 
component greater than 50 mm. However, the difficulty in com-
paring this to all primary conventional total hip replacements 
is that most resurfacing procedures used a single prosthesis 
(BHR) that has been identified as having one of the lowest 
risks of revision. There are individual conventional total hip 
prostheses that the Registry reports as having a lower risk of 
Table 1. Annual cumulative per cent revision (with 95% CI) of primary total resurfacing hip replacement
Head component   Acetabular 
  component   n (total)   1 year   3 years   5 years   7 years   8 years
ASR   ASR   1,073   3.6 (2.6–4.9)   6.0 (4.6–7.8)   8.7 (6.6–12)  
Adept   Adept   292   0.7 (0.2–2.7)   1.9 (0.7–5.1)   
BHR   BHR   8,427   1.5 (1.3–1.8)   2.5 (2.2–2.9)   3.6 (3.2–4.1)   4.8 (4.2–5.6)   5.0 (4.3–5.8)
Bionik   Bionik   119   4.3 (1.6–11)   6.7 (2.6–16.4)   
Conserve Plus   Conserve Plus   62   3.2 (0.8–12)   5.1 (1.7–15)   9.7 (4.1–22)   9.7 (4.1–22) 
Cormet   Cormet   192   1.6 (0.5–4.8)   3.8 (1.8–7.9)   5.3 (2.8–10)   6.0 (7.1–34) 
Cormet 2000 HAP   Cormet   95   6.3 (2.9–14)   8.4 (4.3–16)   9.5 (5.0–17)  
Cormet HAP BiCoat   Cormet   287   2.8 (1.3–5.8)   5.0 (2.6–9.5)   
Durom   Durom   767   3.0 (2.0–4.5)   4.7 (3.4–6.7)   6.7 (4.7–9.7)  
Icon   Icon   96   1.1 (0.2–7.9)   2.5 (0.6–9.6)   
Mitch TRH   Mitch TRH   534   1.4 (0.6–3.1)    
Recap   Recap  137  5.0 (2.3–11)   7.6 (3.8–15)   
Note: 2 resurfacing hip procedures using only a Conserve resurfacing head and no acetabular component have been excluded.
Table 2. Type of revision of primary total resur-
facing hip replacement
Type of revision    n   %
 
Femoral only   252   58
THR (femoral/acetabular)   135   31
Acetabular only   37   9
Cement spacer   9   2
Removal of prosthesis   4   1
Total   437   100
Table 3. Reason for revision of primary total 
resurfacing hip replacement
Revision diagnosis    n   %
Fracture   172   39
Loosening/lysis   128   29
Infection   39   9
Metal sensitivity   28   6
Pain   23   5
Dislocation of prosthesis   14   3
Other   33   8
Total   437   10070  Acta Orthopaedica 2010; 81 (1): 66–71
revision than the reported overall risk of all conventional total 
hip prostheses (AOANJRR Annual Report 2009). 
The  rate  of  revision  of  resurfacing  appears  to  be  higher 
in females, and both sexes show an increasing revision rate 
with age. The higher revision rate in female patients can be 
accounted for by differences in the proportion of males and 
females who receive smaller sizes of femoral components. 
Head sizes of less than 50 mm have a higher risk of revision, 
but occur more frequently in the female population. These 
observations on femoral component size have been suggested 
previously. In a study of Conserve Plus hip resurfacings in 355 
patients (400 hips), Amstutz et al. (2004) reported that female 
and male patients with smaller femoral component head sizes 
had more femoral loosening and radiolucencies. The authors 
concluded that femoral fixation is critical to long-term durabil-
ity, and individuals with smaller head sizes have a smaller area 
available for cement fixation. The THARIES hip resurfacing 
also showed a lower survival rate for smaller heads (39%) than 
for larger component sizes (59%) at 11 years (Mai et al. 1996). 
However, other authors (Shimmin and Back 2005, Kim et al. 
2008) have not reported any association between femoral head 
size and increased revision rate.
Even with head sizes of 50 mm and above, there was an 
increasing risk of revision with increasing age. This is presum-
ably due to deteriorating bone quality. Thus, one might expect 
that women would have higher revision rates but our data sug-
gest that being female is not a risk factor for revision of hip 
resurfacing. In fact, the relatively small number of females 
with head sizes of 50 mm and above 404 appear to have better 
survival rates than males (Figure 5). This observation may be 
due to differences in the selection process between the sexes, 
with many surgeons performing DEXA scans to assess bone 
density in females before performing hip resurfacing.
Patients  with  developmental  hip  dysplasia  (DDH)  had  a 
higher risk of revision than those with primary osteoarthritis 
(OA). The 5-year CPR for DDH in patients aged less than 55 
was more than 3 times that for OA (13 and 4, respectively). 
Schmalzried et al. (2005) reported that the outcome of hip 
resurfacing  is  dependent  on  the  preoperative  radiographic 
characteristics of the proximal femur (in terms of bone den-
sity, shape, limb length discrepancy, and neck shaft angle), 
with more normal morphology giving better outcome. The 
Registry data support these observations, with patients with 
abnormal anatomy—as in DDH—having a higher risk of revi-
sion than OA patients.
The 5-year CPR for AVN was higher than for OA (6 and 4, 
respectively) but this was not statistically significant. It has 
been reported that cysts in the femoral head are associated with 
early revision of hip resurfacing (Amstutz et al. 2004, Beaule 
et al. 2004). However, total hip replacement in young patients 
with AVN has generally been reported to have higher revision 
rates than in patients with primary OA. Early to medium-term 
revision rates of 39–57% have been reported (Chandler et al. 
1981, Cornell et al. 1985, Saito et al. 1989, Mai et al. 1996, 
Callaghan et al. 1997, Beaule et al. 2004). The 5-year survival 
of hip resurfacing for AVN from our analysis (94%) is similar 
to that in other recently published series (Mont et al. 2006, 
Revell et al. 2006). 
We found a difference in outcome related to the type of pros-
thesis used. The Durom, ASR, Cormet 2000 HAP, and Recap 
all had a higher rate of revision than other resurfacing prosthe-
ses. There may be many reasons for this, including differences 
in the patient population or surgeons, or in prosthesis designs. 
In our analysis, we considered all of these factors but found 
no patient-specific or surgeon-specific factors that might have 
contributed to the difference. Furthermore, this did not appear 
to be related to the later introduction of these prostheses (com-
pared to the BHR) onto the Australian market, as there have 
been a number of other recent prostheses with a similar out-
come to that of the BHR and other resurfacing prostheses. The 
difference in fracture rate between different prostheses may 
be related to the different designs and methods of preparing 
the femoral head.
Interpretation
Although the Australian Joint Registry shows that, overall, 
hip resurfacings are revised more often than total hip replace-
ments at up to 8 years, it also shows that hip resurfacing has 
a similar outcome to that of primary conventional total hip 
replacement in selected patients. Smaller femoral component 
sizes, increasing patient age, a diagnosis of developmental 
dysplasia of the hip, and some implant designs are risk factors 
for revision. The lowest cumulative per cent revision (3 at 7 
years) was in patients aged less than 55 years with primary 
osteoarthritis and with femoral component sizes of ≥ 50 mm. 
It is too early to tell whether the perceived long-term benefits 
of hip resurfacing in this patient group will become appar-
ent.
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